Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Teche Holding Company (“Teche” or the “Company”) (NYSE MKT: TSH) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval for a an advisory proposal on the Company's executive compensation.
Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on January 4, 2013, the Board of Directors recommends that Teche's shareholders vote to approve a non-binding advisory proposal regarding the Company's executive compensation. The issuance of the additional shares could have a substantial dilutive effect on the shares of Teche common stock.
Request more information now by clicking here: www.faruqilaw.com/TSH. There is no cost or obligation to you.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients.
If you own common stock in Teche and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/TSH or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.
Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New
York, NY 10017
Attn: Juan E. Monteverde, Esq.
jmonteverde@faruqilaw.com
Toll
Free: (877) 247-4292
Phone: (212) 983-9330
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.